Stay updated on IMAB362 with EOX Regimen in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMAB362 with EOX Regimen in Gastric Cancer Clinical Trial page.

Latest updates to the IMAB362 with EOX Regimen in Gastric Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference2%
- Check22 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%
- Check36 days agoChange DetectedUpdated to v3.0.2, replacing v3.0.1; the 'Back to Top' element was removed.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%
- Check50 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location details, as well as the introduction of various chemical compounds and drugs, notably Zolbetuximab. Several previous location references and medical terms have been removed, indicating a shift in focus or content structure.SummaryDifference6%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to IMAB362 with EOX Regimen in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 with EOX Regimen in Gastric Cancer Clinical Trial page.